Daratumumab in immune-mediated thrombotic thrombocytopenic purpura: emerging evidence for plasma cell-targeted therapy.
- DOI
- 10.1080/16078454.2026.2753240
- Published
- 2026-10-29
- Container
- Hematology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/16078454.2026.2753240,
title = {Daratumumab in immune-mediated thrombotic thrombocytopenic purpura: emerging evidence for plasma cell-targeted therapy.},
author = {Mohammed Saleh MF and Alzaidy N and Nassani M and Abdrabou AK and Nasiri A and Alzahrani H.},
year = {2026},
journal = {Hematology},
doi = {10.1080/16078454.2026.2753240},
url = {https://doi.org/10.1080/16078454.2026.2753240}
}RIS
TY - JOUR TI - Daratumumab in immune-mediated thrombotic thrombocytopenic purpura: emerging evidence for plasma cell-targeted therapy. AU - Mohammed Saleh MF AU - Alzaidy N AU - Nassani M AU - Abdrabou AK AU - Nasiri A AU - Alzahrani H. PY - 2026 JO - Hematology DO - 10.1080/16078454.2026.2753240 UR - https://doi.org/10.1080/16078454.2026.2753240 ER -
APA
MF, M. S., N, A., M, N., AK, A., A, N., & H., A. (2026). Daratumumab in immune-mediated thrombotic thrombocytopenic purpura: emerging evidence for plasma cell-targeted therapy.. Hematology. https://doi.org/10.1080/16078454.2026.2753240
Source records
- europe-pmc · retrieved 2026-11-10T12:40:13.272Z